Literature DB >> 19054676

An unusual complication of immunosuppression in myasthenia gravis: progressive multifocal leukoencephalopathy.

Muhteşem Gedizlioglu1, Pinar Coban, Pinar Ce, Izlem Evren Sivasli.   

Abstract

We present a 44-year-old female patient with generalised myasthenia gravis who developed progressive multifocal leukoencephalopathy. She was receiving high dose corticosteroids, azathioprine 200mg daily and high dose intravenous immunoglobulin during relapses. Two months after thymectomy she presented with progressive cognitive decline, asymmetric quadriparesis and ataxia. Two months later she was bedridden. Cranial MRI showed large asymmetric T2 and FLAIR hyperintense lesions in cortical and subcortical structures. Positive CSF PCR of JC virus confirmed the diagnosis. The patient survives with severe sequela which confirms slow progression as typical in nonAIDS cases. This is the second case of progressive multifocal leukoencephalopathy in a myasthenic patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19054676     DOI: 10.1016/j.nmd.2008.09.019

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

1.  PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents.

Authors:  Kiran M Kanth; Guillermo E Solorzano; Myla D Goldman
Journal:  Neurol Clin Pract       Date:  2016-04

Review 2.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

3.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

4.  Progressive multifocal leukoencephalopathy associated with thymoma with immunodeficiency: a case report and literature review.

Authors:  Tatsuya Ueno; Nobuyuki Sato; Tomoya Kon; Rie Haga; Jin-Ichi Nunomura; Kazuo Nakamichi; Masayuki Saijo; Masahiko Tomiyama
Journal:  BMC Neurol       Date:  2018-04-10       Impact factor: 2.474

Review 5.  International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.

Authors:  Pushpa Narayanaswami; Donald B Sanders; Gil Wolfe; Michael Benatar; Gabriel Cea; Amelia Evoli; Nils Erik Gilhus; Isabel Illa; Nancy L Kuntz; Janice Massey; Arthur Melms; Hiroyuki Murai; Michael Nicolle; Jacqueline Palace; David Richman; Jan Verschuuren
Journal:  Neurology       Date:  2020-11-03       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.